[1]
Heidari, A. et al. 2021. Active targeting of rhenium (iv) oxide (ReO2), rhenium trioxide (ReO3) and rhenium (vii) oxide (Re2O7) nanoparticles as cancer therapeutics swell-up to kill cancer cells under synchrotron and synchrocyclotron radiations. International Journal of Advanced Chemistry. 9, 2 (Sep. 2021), 103–121. DOI:https://doi.org/10.14419/ijac.v9i2.31656.